Patent: 8,383,144
✉ Email this page to a colleague
Summary for Patent: 8,383,144
| Title: | Tissue adhering compositions |
| Abstract: | A method mixes a first component, a second component, and a buffer material. The first component includes an electrophilic polymer material comprising poly(ethylene glycol) having a functionality of at least three. The second component includes a nucleophilic material comprising a natural or synthetic protein at a concentration of about 25% or less that, when mixed with the first component within a reaction pH range, cross-links with the first component to form a non-liquid, three-dimensional barrier. The buffer material includes tris-hydroxymethylaminomethane having a pH within the reaction pH range. The method applies the mixture to adhere to a tissue region. |
| Inventor(s): | Hnojewyj; Olexander (Saratoga, CA) |
| Assignee: | Neomend, Inc. (Irvine, CA) |
| Application Number: | 12/641,215 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,383,144
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | ZOSTAVAX | zoster vaccine live | For Injection | 125123 | 05/25/2006 | ⤷ Try a Trial | 2018-11-06 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
